Keyphrases
Digital Examination
100%
Thyroid Function Tests
100%
Experimental Surgery
100%
Neobladder
100%
Blood Concentration
100%
Patients with Prostate Cancer
100%
Learning Curve
100%
Pig Kidney
100%
Conventional Surgery
100%
Oportunity
100%
Androgen Deprivation Therapy
100%
Pig Model
100%
Free PSA
100%
Porcine Model
100%
Training Program
100%
Kidney Transplant
100%
Urinary Markers
100%
Transplantation Model
100%
Transplant Surgery
100%
Renal Transplant
100%
Living Donor
100%
Resident Training
100%
Surgical Technique
100%
Experimental pigs
100%
Martius Flap
100%
Non-muscle Invasive Bladder Cancer (NMIBC)
100%
Cystoscopy
85%
Transcription Factor
80%
Neobladder-vaginal Fistula
75%
Serum Levels
60%
Thyroid Hormones
50%
Prostate Biopsy
42%
Serum PSA
42%
Surveillance Protocol
40%
Negative Predictive Value
40%
Bladder Cancer Diagnosis
40%
Urinary Biomarkers
40%
Coefficient of Variation
28%
PSA Level
28%
Intra-individual Variation
28%
Two-layer
25%
Fistula
25%
Catheter Removal
25%
Vaginal Closure
25%
Cystectomy
25%
Older Patients
25%
Vaginal Approach
25%
Bladder Paraganglioma
25%
Urethral Catheter
25%
Cochrane Library
20%
Medicine and Dentistry
Neobladder
100%
Non Muscle Invasive Bladder Cancer
100%
Urinary System
100%
Thyroid Function Test
100%
Prostate Cancer
100%
Androgen Deprivation Therapy
100%
Transcription Factors
80%
Cystoscopy
74%
Thyrotropin
50%
Vagina Disease
42%
Cancer Epidemiology
40%
Biological Marker
40%
Cytotechnology
40%
False Positive Result
20%
Cancer Recurrence
20%
Protein Determination
20%
Bladder Cancer
20%
Health Care Cost
20%
Hypothyroidism
20%
Thyroxine
20%
Gonadorelin Agonist
20%
Catheter Removal
14%
Bladder Carcinoma
14%
Fistula
14%
Cystectomy
14%
Prostatectomy
10%
Liothyronine
10%
Prostate Specific Antigen
10%
Hormone Determination
10%
Bicalutamide
10%
Cross Sectional Study
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Porcine Model
100%
Androgen
100%
Non Muscle Invasive Bladder Cancer
100%
Transcription Factors
80%
Experimental Pig
50%
Thyrotropin
50%
Cancer Epidemiology
40%
Biological Marker
40%
Gonadorelin Agonist
20%
Thyroxine
20%
Hypothyroidism
20%
Bladder Cancer
20%
Cancer Recurrence
20%
Bicalutamide
10%
Prostate Specific Antigen
10%
Liothyronine
10%
Cross-Sectional Study
10%